Venus Remedies Ltd
₹967.40
(3.65%)
Fri, 08 May 2026, 00:46 pm
Health Technology
Pharmaceuticals: Major
24.5KVenus Remedies Share Price Live Chart
1 Day
0 (0%)
No Result Found
Summary
Market Cap
1296.46
Net Profit
45.31
P/B
0.71
Sector P/E
34.49
P/E
8.84
EV/EBITDA
3.41
Debt/Equity (Industry)
0.47
Interest Cover (Industry)
5.19
ROCE (Industry)
14.14
RONW (Industry)
11.70
ROE
7.16
ROCE
10.93
Debt/Equity
0.04
EPS (TTM)
57.09
Dividend Yield
0
Book Value
444.61
Interest Cover
862.13
Analysis
all
- Whilst loss making Venus Remedies has sufficient cash runway for more than 3 years, even with free cash flow being positive and shrinking by -52.4% per year.
- Whilst loss making Venus Remedies has sufficient cash runway for more than 3 years if it maintains the current positive free cash flow level.
- Debt is well covered by operating cash flow (31.8%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 1.3x debt.
- Venus Remedies's cash and other short term assets cover its long term commitments.
- Unable to calculate sustainability of dividends as Venus Remedies has not reported any payouts.
- Unable to evaluate Venus Remedies's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Venus Remedies's dividend against the top 25% market benchmark as the company has not reported any payouts.
- Venus Remedies's short term (1 year) commitments are greater than its holdings of cash and other short term assets.
- Venus Remedies is making a loss, therefore interest payments are not well covered by earnings.
Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 41.76 | 41.76 | 41.76 | 41.76 | 41.76 |
| FII | 2.80 | 2.26 | 1.86 | 2.24 | 1.34 |
| DII | 1.20 | 1.03 | 0.75 | 0.11 | 0 |
| Public | 54.24 | 54.96 | 55.63 | 55.89 | 56.90 |
| Government | 0 | 0 | 0 | 0 | 0 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1477.83 | 1220.13 | 1093.77 | 962.43 | 836.07 | 704.73 | 447.03 |
| Fibonacci | 1220.13 | 1121.69 | 1060.87 | 962.43 | 863.99 | 803.17 | 704.73 |
| Camarilla | 1038.27 | 1014.64 | 991.02 | 962.43 | 943.78 | 920.15 | 896.53 |
Pivots Level: Classic
R3
+515.40
1477.83
R2
+257.70
1220.13
R1
+131.33
1093.77
S1
-126.37
836.07
S2
-257.70
704.73
S3
-515.40
447.03
Moving Average
Period
Value
10-EMA
969.32
20-EMA
961.54
30-EMA
943.78
50-EMA
905.36
100-EMA
824.06
200-EMA
706.96
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 29 Jan 2026 | board-meetings | Quarterly Results | |
| 10 Nov 2025 | board-meetings | Quarterly Results | |
| 08 Jul 2025 | agm | ||
| 21 Aug 2024 | agm | ||
| 13 Aug 2024 | agm | Annual General Meeting | 17 Sept 2024 |
| 17 Jul 2023 | agm | Annual General Meeting | 18 Aug 2023 |
| 15 Jul 2023 | agm | ||
| 25 Jul 2022 | agm | ||
| 11 Jul 2022 | agm | Annual General Meeting | 17 Aug 2022 |
| 17 Aug 2021 | agm |
Peer Comparison
Venus Remedies Ltd
Sun Pharmaceutical Industries Ltd
Torrent Pharmaceuticals Ltd
Lupin Ltd
Divis Laboratories Ltd
Cipla Ltd
Venus Remedies Ltd About
Venus Remedies is one of the handful player in pharmaceutical sector to launch injectables globally. It has world-class manufacturing facilities in Panchkula and Baddi (in India), and research and development centre under the name of Venus Medicine Research Centre.
Industry
Pharmaceuticals - Indian - Formulations
Founded
1989
Headquarters
CEO
Pawan Chaudhary
Employees
Contact
Website
http://www.venusremedies.com
investorgrievance@venusremedies.com; complianceoff
Phone
Location
S C No 857 Cabin No 10 2nd Flr, N A C Manimajra, Chandigarh, Chandigarh, 160101
Venus Remedies Ltd Company History
| Year | History |
|---|---|
| 2019 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|
| PRADEEP KUMAR JAIN | Sell | 135966 | 422.77 | 30 May 2025 |
| SAMYAK ENTERPRISES | Buy | 90000 | 292.7 | 21 Mar 2025 |
| MC JAIN INFOSERVICES PRIVATE LIMITED | Sell | 90000 | 292.7 | 21 Mar 2025 |
| PARTH INFIN BROKERS PVT LTD | Buy | 125195 | 354.83 | 06 Feb 2025 |
| PARTH INFIN BROKERS PVT LTD | Sell | 114490 | 353.88 | 06 Feb 2025 |
| CRONY VYAPAR PVT LTD | Sell | 50190 | 352.6 | 06 Feb 2025 |
| CRONY VYAPAR PVT LTD | Buy | 75190 | 356.91 | 06 Feb 2025 |
| GRAVITON RESEARCH CAPITAL LLP | Buy | 68957 | 376.56 | 13 Jun 2024 |
| GRAVITON RESEARCH CAPITAL LLP | Sell | 68957 | 377.21 | 13 Jun 2024 |
| BNP PARIBAS ARBITRAGE | Sell | 66948 | 380.24 | 24 Jan 2024 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800